James Yao

558 total citations
9 papers, 433 citations indexed

About

James Yao is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, James Yao has authored 9 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in James Yao's work include Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). James Yao is often cited by papers focused on Lung Cancer Research Studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). James Yao collaborates with scholars based in United States, China and United Kingdom. James Yao's co-authors include Keping Xie, Daoyan Wei, Zhiliang Jia, Qiang Li, Yixing Jiang, Weida Gong, Shengyun Fang, Jun Zhang, Liwei Wang and Rodney F. Pommier and has published in prestigious journals such as Cancer, Clinical Cancer Research and Journal of Hematology & Oncology.

In The Last Decade

James Yao

9 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Yao United States 8 207 186 159 117 75 9 433
Tadashi Hayasaka Japan 8 287 1.4× 185 1.0× 84 0.5× 18 0.2× 34 0.5× 16 511
Tom Mikkelson United States 5 287 1.4× 72 0.4× 312 2.0× 51 0.4× 25 0.3× 6 530
Olaf Klingbeil United States 12 425 2.1× 316 1.7× 152 1.0× 28 0.2× 28 0.4× 17 685
Hala Elnakat Thomas United States 9 312 1.5× 68 0.4× 145 0.9× 45 0.4× 21 0.3× 9 460
Masumi Yoshie Japan 8 191 0.9× 135 0.7× 51 0.3× 50 0.4× 11 0.1× 15 392
Yutaka Tamada Japan 9 244 1.2× 47 0.3× 236 1.5× 69 0.6× 11 0.1× 13 414
Christopher M. Dower United States 7 230 1.1× 58 0.3× 163 1.0× 43 0.4× 24 0.3× 9 373
Wenjuan Zhang China 13 502 2.4× 206 1.1× 112 0.7× 64 0.5× 8 0.1× 28 609
Rui-Qing Peng China 10 222 1.1× 239 1.3× 182 1.1× 81 0.7× 8 0.1× 15 550
Brittany Durden United States 8 252 1.2× 195 1.0× 50 0.3× 69 0.6× 11 0.1× 8 456

Countries citing papers authored by James Yao

Since Specialization
Citations

This map shows the geographic impact of James Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Yao more than expected).

Fields of papers citing papers by James Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Yao. The network helps show where James Yao may publish in the future.

Co-authorship network of co-authors of James Yao

This figure shows the co-authorship network connecting the top 25 collaborators of James Yao. A scholar is included among the top collaborators of James Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Yao. James Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Buzzoni, Roberto, Carlo Carnaghi, Jonathan Strosberg, et al.. (2017). Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4. OncoTargets and Therapy. Volume 10. 5013–5030. 9 indexed citations
2.
Atiq, Muslim, Manoop S. Bhutani, Mehmet Bektaş, et al.. (2011). EUS-FNA for Pancreatic Neuroendocrine Tumors: A Tertiary Cancer Center Experience. Digestive Diseases and Sciences. 57(3). 791–800. 61 indexed citations
3.
Kulke, Matthew H., Johanna C. Bendell, Larry K. Kvols, et al.. (2011). Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors. Journal of Hematology & Oncology. 4(1). 29–29. 62 indexed citations
4.
Wang, Liwei, Xiaohong Guan, Jun Zhang, et al.. (2008). Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. International Journal of Oncology. 33(1). 161–7. 35 indexed citations
5.
Yuan, Ping, Liwei Wang, Daoyan Wei, et al.. (2007). Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer. 110(12). 2682–2690. 70 indexed citations
6.
Zhang, Jun, Yixing Jiang, Zhiliang Jia, et al.. (2006). Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clinical & Experimental Metastasis. 23(7-8). 401–410. 159 indexed citations
7.
Wang, Liwei, Xiaohong Guan, Weida Gong, et al.. (2005). Altered Expression of Transcription Factor Sp1 Critically Impacts the Angiogenic Phenotype of Human Gastric Cancer. Clinical & Experimental Metastasis. 22(3). 205–213. 16 indexed citations
8.
Gong, Weida, Yixing Jiang, Liwei Wang, et al.. (2005). Expression of Autocrine Motility Factor Correlates with the Angiogenic Phenotype of and Poor Prognosis for Human Gastric Cancer. Clinical Cancer Research. 11(16). 5778–5783. 17 indexed citations
9.
Kumar, Ashok, et al.. (2003). Leptomeningeal Carcinomatosis Originating from Gastric Cancer. American Journal of Clinical Oncology. 26(2). 165–170. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026